Dogwood Therapeutics DWTX Total Operating Expenses
Total Operating Expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total operating expenses?
- Dogwood Therapeutics (DWTX) reported total operating expenses of $5.08M in Q1 2026.
- How has Dogwood Therapeutics's total operating expenses changed year-over-year?
- Dogwood Therapeutics's total operating expenses increased by 14.6% year-over-year, from $4.43M to $5.08M.
- What is the long-term trend for Dogwood Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's total operating expenses has grown at a 15.6% compound annual growth rate (CAGR), from $15.64M to $27.97M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.